跳至主要内容
临床试验/JPRN-jRCT2080221473
JPRN-jRCT2080221473未知3 期

Open-label study to assess efficacy and safety of a single dose (i.v.) of NMA78 in patients with Dementia with Lewy Bodies (DLB) or Alzheimer's Disease (AD) and healthy volunteers (HV)

ihon Medi-Physics Co., Ltd.0 个研究点目标入组 18 人开始时间: 2011年6月1日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 35age old 至 ot applicable(—)
性别
All

入选标准

  • -Healthy Japanese people.
  • -Japanese patients clinically- diagnosed with DLB.
  • -Japanese patients clinically- diagnosed with AD.

排除标准

  • -People using following drugs: cocaine hydrochloride, mazindol, methylphenidate hydrochloride, sertraline hydrochloride.
  • -Patients with hepatic, renal or hematopoietic dysfunction.
  • -People with allergic reaction to alcohol or iodine.
  • -Women who are pregnant, lactating or possibly pregnant.

研究者

发起方
ihon Medi-Physics Co., Ltd.

相似试验